Oct 14, 2026 05:00PM
Oct 14, 2026 05:00PM
Oct 5, 2026 06:50AM
Sep 29, 2026 07:10PM
Sep 29, 2026 06:45PM
Aug 24, 2026 07:04AM
Aug 24, 2026 07:00AM Vanda Pharmaceuticals Granted Orphan Designation for Imsidolimab for the Treatment of Generalized Pustular Psoriasis by the European Commission
Aug 22, 2026 03:16PM
Aug 5, 2026 04:01PM
Jul 16, 2026 04:30PM
Jul 16, 2026 04:30PM
Jul 15, 2026 04:30PM
Jul 9, 2026 06:51AM
Jul 7, 2026 04:31PM FDA grants Vanda rare pediatric disease tag for CMT2S therapy
Jul 7, 2026 04:30PM
Jun 4, 2026 06:42AM
May 6, 2026 04:01PM
May 4, 2026 08:02AM
May 4, 2026 08:00AM
May 1, 2026 04:36PM
May 1, 2026 04:35PM Vanda Pharmaceuticals Announces U.S. Commercial Availability of NEREUS™ (tradipitant), the First New Pharmacologic Treatment for People with Motion Sickness in More Than 40 Years
Apr 28, 2026 07:12PM
Apr 9, 2026 11:03AM
Apr 9, 2026 11:02AM
Apr 9, 2026 06:42AM
Apr 8, 2026 04:45PM
Apr 8, 2026 04:44PM
Mar 19, 2026 04:34PM Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from Animal Testing to Human-Relevant Methods
Mar 3, 2026 08:03AM
Mar 3, 2026 08:01AM
Feb 25, 2026 07:19AM
Feb 25, 2026 07:18AM
Feb 23, 2026 06:36AM
Feb 23, 2026 05:19AM
Feb 20, 2026 05:59PM Vanda gets FDA approval for psychiatric drug BYSANTI
Feb 20, 2026 05:59PM
Feb 11, 2026 04:01PM
Jan 8, 2026 07:01AM
Jan 8, 2026 07:00AM
Jan 5, 2026 06:41AM
Dec 31, 2025 04:25AM
Dec 30, 2025 06:13PM FDA approves Vanda's NEREUS for motion sickness prevention
Dec 30, 2025 06:13PM
Dec 17, 2025 07:30AM
Dec 15, 2025 07:01AM
Dec 15, 2025 07:00AM
Dec 4, 2025 04:22PM
Dec 4, 2025 04:21PM
Dec 1, 2025 06:35AM H.C. Wainwright Reiterates Buy Rating on Vanda Pharmaceuticals (VNDA)
Nov 28, 2025 07:00AM

335,055 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All